-
MannKind Shares Are falling Today: What's Going On?
16 Dec 2024 21:30 GMT
MannKind Corporation MNKD are trading lower … regulatory response.
MNKD Price Action: MannKind shares were down 4.28% at …
-
MannKind Corporation Announces Exchange of Convertible Notes for Stock and Cash
18 Dec 2024 12:00 GMT
… stock (“Shares”). In addition, pursuant to the exchange agreements, MannKind will make … approximately 302.5 million shares outstanding. The shares of MannKind’s common stock … sale would be unlawful. About MannKind
MannKind Corporation (Nasdaq: MNKD) focuses …
-
MannKind Stock Gains After India Approves Inhaled Insulin: Retail Excitement Builds
11 Dec 2024 14:41 GMT
… 6:52 PM IST
Shares of MannKind Corporation climbed more than … United States and Brazil.
MannKind’s exclusive marketing and …
Michael Castagna, CEO of MannKind, expressed optimism about the … of 2025,” he added.
MannKind shares have risen over 70% year …
-
Cipla shares in focus after receiving CDSCO nod to launch inhalation insulin
12 Dec 2024 02:51 GMT
… developed and manufactured by MannKind Corporation (MannKind) USA, is used to … management by partnering with MannKind for distribution of Afrezza … of thousands of patients. MannKind will supply Afrezza to … here?
On Wednesday, Cipla shares closed at Rs 1454.2 …
-
MannKind keeps hitting higher revenues
12 Nov 2024 06:17 GMT
… third quarter of 2024.
MannKind, a biotechnology company that … idiopathic pulmonary fibrosis.
Afrezza, MannKind’s key product, an inhaled … gross-to-net adjustments.
MannKind shares closed at $7.22 … 11. Shares are up 84% year-to-date.
MannKind closed the …
-
MannKind Corporation Reports 2024 Third Quarter Financial Results and Provides Business Update
07 Nov 2024 21:02 GMT
… for approximately 90 days. About MannKind MannKind Corporation (Nasdaq: MNKD) focuses … are registered trademarks of MannKind Corporation.
MANNKIND CORPORATION AND SUBSIDIARY
… shares issuable upon conversion of our Mann Group convertible note.
MANNKIND …
-
MannKind Corporation Reports 2024 Second Quarter Financial Results: Provides Clinical Development Update
07 Aug 2024 12:00 GMT
… diluted weighted average shares as reported in our … (0.02
)
Weighted average shares used to compute net income … approximately 90 days. About MannKind MannKind Corporation (Nasdaq: MNKD) … registered trademarks of MannKind Corporation.
MANNKIND CORPORATION AND …
-
MannKind Shares Rise 6.6% After Selling 1% Royalty Interest In Tyvaso DPI
02 Jan 2024 19:56 GMT
Shares of MannKind rose Tuesday after the drugmaker … $3.88 in afternoon trading. Shares were up as much as … -disease treatment, was licensed by MannKind to United Therapeutics in 2018 …
-
MannKind (MNKD) Q1 2024 Earnings Call Transcript
09 May 2024 05:19 GMT
… debt into 1.5 million shares to the contractual conversion … dilution by over two million shares that were backing the … thank Mike, the extended MannKind team, the MannKind Board, and those … share count outstanding. Our shares have not gone up when …
-
MannKind Corporation Reports 2024 First Quarter Financial Results: Provides Clinical Development Update
08 May 2024 20:18 GMT
… website for 14 days. About MannKind MannKind Corporation (Nasdaq: MNKD) focuses … GO are registered trademarks of MannKind Corporation. MannKind Contact:
Rose Alinaya, Investor … average shares are only applied to periods with net income.
MANNKIND CORPORATION …